Cargando…

Impact of potassium citrate on urinary risk profile, glucose and lipid metabolism of kidney stone formers in Switzerland

BACKGROUND: Hypocitraturia and hypercalciuria are the most prevalent risk factors in kidney stone formers (KSFs). Citrate supplementation has been introduced for metaphylaxis in KSFs. However, beyond its effects on urinary parameters and stone recurrence, only a few studies have investigated the imp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wiegand, Anna, Fischer, Gioia, Seeger, Harald, Fuster, Daniel, Dhayat, Nasser, Bonny, Olivier, Ernandez, Thomas, Kim, Min-Jeong, Wagner, Carsten A, Mohebbi, Nilufar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7769539/ https://www.ncbi.nlm.nih.gov/pubmed/33391747 http://dx.doi.org/10.1093/ckj/sfz098

Ejemplares similares

Urinary tetrahydroaldosterone is associated with circulating FGF23 in kidney stone formers
por: Moor, Matthias B., et al.
Publicado: (2022)

Changes in urinary nanocrystallites in calcium oxalate stone formers before and after potassium citrate intake
por: Duan, Chao-Yang, et al.
Publicado: (2013)

Changes in urinary risk profile after short-term low sodium and low calcium diet in recurrent Swiss kidney stone formers
por: Seeger, Harald, et al.
Publicado: (2017)

Predictors of Bone Mineral Density in Kidney Stone Formers
por: Dhayat, Nasser A., et al.
Publicado: (2021)

Evidence for abnormal linkage between urine oxalate and citrate excretion in human kidney stone formers
por: Prochaska, Megan L., et al.
Publicado: (2021)

Urine and stone analysis for the investigation of the renal stone former: a consensus conference
por: Williams, James C., et al.
Publicado: (2020)

Urinary Calcium Is Associated with Serum Sclerostin among Stone Formers
por: Rodrigues, Fernanda Guedes, et al.
Publicado: (2023)

Urinary metabolic profile and stone composition in kidney stone formers with and without heart disease
por: Bargagli, Matteo, et al.
Publicado: (2021)

Ectopic biomineralization in kidney stone formers compared to non-stone formers
por: Fernandez, Adrian M., et al.
Publicado: (2020)

Methods for the dietary assessment of adult kidney stone formers: a scoping review
por: Legay, Constance, et al.
Publicado: (2022)

The safety of ureteral stenting with the use of potassium citrate for management of renal uric acid stones
por: Alenezi, Nawaf Abdulaziz, et al.
Publicado: (2020)

A Pilot Study of the Effect of Sodium Thiosulfate on Urinary Lithogenicity and Associated Metabolic Acid Load in Non-Stone Formers and Stone Formers with Hypercalciuria
por: Okonkwo, Onyeka W., et al.
Publicado: (2013)

Urinary pH in calcium oxalate stone formers: does it matter?
por: Carvalho, Mauricio
Publicado: (2018)

Serum and 24-hour urinary tests cost-effectiveness in stone formers
por: Mohammadi, Abdolreza, et al.
Publicado: (2023)

Seasonal variations in urinary calcium, volume, and vitamin D in kidney stone formers
por: Attalla, Kyrollis, et al.
Publicado: (2018)

Sodium/Glucose Cotransporter 2 Inhibition and Urolithiasis: The Effect of Urinary pH and Citrate
por: Harmacek, Dusan, et al.
Publicado: (2023)

Potassium Iodide and Citrates in Pneumonia
Publicado: (1909)

Improving the compliance of the recurrent stone-former
por: Fritsche, Hans-Martin, et al.
Publicado: (2012)

Precision medicine in renal stone-formers
por: Hill, Fay, et al.
Publicado: (2018)

Oral chemolysis is an effective, non-invasive therapy for urinary stones suspected of uric acid content
por: Tsaturyan, Arman, et al.
Publicado: (2020)

A new device for simple and accurate urinary pH testing by the Stone-former patient
por: Grases, Felix, et al.
Publicado: (2014)

Estimating 24-hour urinary excretion using spot urine measurements in kidney stone formers
por: Ferraro, Pietro Manuel, et al.
Publicado: (2022)

Simple dietary advice targeting five urinary parameters reduces urinary supersaturation in idiopathic calcium oxalate stone formers
por: Sromicki, Juri, et al.
Publicado: (2020)

Kidney stone formers have more renal parenchymal crystals than non-stone formers, particularly in the papilla region
por: Okada, Atsushi, et al.
Publicado: (2018)

Does potassium citrate administration change the type and composition of encrusted material on Double-J stent compared to primary stone?
por: Mohammadi, Abdolreza, et al.
Publicado: (2021)

Urolithiasis: Update on Metabolic Evaluation of Stone Formers
por: Park, Sangtae, et al.
Publicado: (2005)

The effectiveness of citrates and pyridoxine in the treatment of kidney stones
por: Ene, Mihai Andrei, et al.
Publicado: (2023)

Description of Stone Morphology and Crystalluria Improve Diagnosis and Care of Kidney Stone Formers
por: Letavernier, Emmanuel, et al.
Publicado: (2022)

Efficacy of standard and low dose hydrochlorothiazide in the recurrence prevention of calcium nephrolithiasis (NOSTONE trial): protocol for a randomized double-blind placebo-controlled trial
por: Dhayat, Nasser A., et al.
Publicado: (2018)

Differences of Uric Acid Transporters Carrying Extracellular Vesicles in the Urine from Uric Acid and Calcium Stone Formers and Non-Stone Formers
por: Lin, Zhijian, et al.
Publicado: (2022)

A Rare Genetic Mutation in a Stone Former
por: Raj, T. Yashwanth, et al.
Publicado: (2021)

Metabolic assessment in pure struvite stones formers: is it necessary?
por: Danilovic, Alexandre, et al.
Publicado: (2021)

Influence of nutritional status, laboratory parameters and dietary patterns upon urinary acid excretion in calcium stone formers.
por: Tessaro, Carolini Zanette Warmling, et al.
Publicado: (2018)

Carbon Nanofibers Based on Potassium Citrate/Polyacrylonitrile for Supercapacitors
por: Zhang, Wang, et al.
Publicado: (2022)

Role of 1,25-Dihydroxy Vitamin D(3) and Parathyroid Hormone in Urinary Calcium Excretion in Calcium Stone Formers
por: Kim, Won Tae, et al.
Publicado: (2014)

Effects of Sex on Intra-Individual Variance in Urinary Solutes in Stone-Formers Collected from a Single Clinical Laboratory
por: Perry, Guy M. L., et al.
Publicado: (2013)

Impact of the SGLT2 inhibitor empagliflozin on urinary supersaturations in kidney stone formers (SWEETSTONE trial): protocol for a randomised, double-blind, placebo-controlled cross-over trial
por: Schietzel, Simeon, et al.
Publicado: (2022)

Can tomato juice be used for prophylaxis in recurrent stone formers?
por: Agrawal, Madhu S., et al.
Publicado: (2009)

Do Kidney Stone Formers Have A Kidney Disease?
por: Zisman, Anna L., et al.
Publicado: (2015)

Metabolic and dietary features in kidney stone formers: nutritional approach
por: Cupisti, Adamasco, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_j9rnlstrja9ua206l0c8ev0cja